This is actually a 1/30/20 article
Inovio Pharma Shares Up 11% With Partnership for Coronavirus Vaccine
10:42 AM ET 1/30/20 | Dow Jones
Related Quotes
4:00 PM ET 2/21/20
Symbol Last % Chg
INO
3.74 0.00%
Quotes delayed at least 15 minutes
By Chris Wack
Inovio Pharmaceuticals Inc. (INO) shares rose 11% to $4.56 after the company said it is collaborating with Beijing Advaccine Biotechnology Co. to advance the development in China of INO-4800, Inovio's vaccine against the recently emerged strain of coronavirus.
Inovio recently said it is developing INO-4800 through Phase 1 human testing in the U.S. to evaluate safety and immunogenicity with the support of an initial grant up to $9 million from the Coalition for Epidemic Preparedness Innovations.
Inovio said it plans to rapidly develop INO-4800 against the new coronavirus, or 2019-nCoV, and has already started preclinical testing and preparations for clinical product manufacturing.
|